Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tonneau

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Experimental and Molecular Pathology|September 17, 2002
Study of disabling T-cell activation and inhibiting T-cell-mediated immunopathology reveals a possible inverse agonist activity of CD4 peptidomimeticsTakeo Horie, Yuan Shen, Kiichi Kajino, et al.
Genome Biology|March 18, 2006
Deciphering cellular states of innate tumor drug responsesEsther Graudens, Virginie Boulanger, Cindy Mollard, et al.
Cancers|January 23, 2024
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary StudyAbdou Khadir Dia, Leyla Ebrahimpour, Sevinj Yolchuyeva, et al.
Clinical and Translational Radiation Oncology|March 4, 2022
<b>S</b>tereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)Houda Bahig, Marion Tonneau, Normand Blais, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 12, 2025
Radiotherapy for lung metastasesAntonin Levy, Marion Tonneau, Julien Darréon, et al.
Journal of Translational Medicine|May 6, 2025
Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patientsAbdou Khadir Dia, Alona Kolnohuz, Sevinj Yolchuyeva, et al.
Arxiv|December 3, 2025
Clinical Validation and Prospective Deployment of an Automated Deep Learning-Based Coronary Segmentation and Cardiac Toxicity Risk Prediction SystemChristian V Guthier, Christopher E Kehayias, Cosmin Ciausu, et al.
Frontiers in Oncology|August 7, 2023
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort studyMarion Tonneau, Kim Phan, Venkata S K Manem, et al.
Oral Oncology|November 25, 2023
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinomaCecilia Hes, Antoine Desilets, Marion Tonneau, et al.
Oncoimmunology|July 14, 2022
<i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitorsMarion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Experimental and Molecular Pathology|September 17, 2002
Study of disabling T-cell activation and inhibiting T-cell-mediated immunopathology reveals a possible inverse agonist activity of CD4 peptidomimeticsTakeo Horie, Yuan Shen, Kiichi Kajino, et al.
Genome Biology|March 18, 2006
Deciphering cellular states of innate tumor drug responsesEsther Graudens, Virginie Boulanger, Cindy Mollard, et al.
Cancers|January 23, 2024
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary StudyAbdou Khadir Dia, Leyla Ebrahimpour, Sevinj Yolchuyeva, et al.
Clinical and Translational Radiation Oncology|March 4, 2022
<b>S</b>tereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)Houda Bahig, Marion Tonneau, Normand Blais, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 12, 2025
Radiotherapy for lung metastasesAntonin Levy, Marion Tonneau, Julien Darréon, et al.
Journal of Translational Medicine|May 6, 2025
Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patientsAbdou Khadir Dia, Alona Kolnohuz, Sevinj Yolchuyeva, et al.
Arxiv|December 3, 2025
Clinical Validation and Prospective Deployment of an Automated Deep Learning-Based Coronary Segmentation and Cardiac Toxicity Risk Prediction SystemChristian V Guthier, Christopher E Kehayias, Cosmin Ciausu, et al.
Frontiers in Oncology|August 7, 2023
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort studyMarion Tonneau, Kim Phan, Venkata S K Manem, et al.
Oral Oncology|November 25, 2023
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinomaCecilia Hes, Antoine Desilets, Marion Tonneau, et al.
Oncoimmunology|July 14, 2022
<i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitorsMarion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian, et al.
Pageof 12